← Back to Patent Explorer
US3818096A Expired / Lapsed US ⏱️ 0.0 years remaining

Compositions of 1,2-dilower alkyl arylpyrazolium quaternary salts and method of lowering blood sugar levels with same

Assignee: Merck Sharp & Dohme LLC
•
Filing: 1972-04-12
•
Granted: 1974-06-18
•
Expires: 1992-04-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pharmaceutical compositions containing a 1,2-dilower alkyl arylpyrazolium quaternary salt as active component are described, along with methods of using same. These active components exhibit hypoglycemic activity as evidenced by their ability to lower blood sugar levels.

Inventors

  • 👤 M Sherlock

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 12:59
CPC Classifications
C; C07; C07D; C07D231/00; C07D231/02; C07D231/06; C07D231/10; C07D231/12

Claims Analysis

Total Claims: 27
Claim 1
Independent Claim 12 words
The composition of claim 1 wherein R1 and R2 are each methyl.
Claim 2
Dependent Claim 19 words
The composition of claim 1 wherein R1 and R2 are each methyl and X is a pharmaceutically acceptable halide.
Claim 3
Dependent Claim 29 words
The composition of claim 1 wherein R1 and R2 are each methyl and R3 is a member selected from the group consisting of phenyl and phenyl substituted by methyl.
Claim 4
Dependent Claim 57 words
The composition of claim 1 wherein R1 and R2 are each methyl, R3 is a member selected from the group consisting of phenyl and phenyl substituted by methyl, R4 is a member selected from the group consisting of hydrogen and lower alkyl and R5 is a member selected from the group consisting of hydrogen, phenyl and methyl.
Claim 5
Dependent Claim 63 words
The composition of claim 1 wherein R1 and R2 are each methyl, R3 is a member selected from the group consisting of phenyl and phenyl substituted by methyl, R4 is a member selected from the group consisting of hydrogen, methyl and ethyl, R5 is a member selected from the group consisting of hydrogen, phenyl and methyl and X is a pharmaceutically acceptable halide.
Claim 6
Dependent Claim 22 words
The composition of claim 1 wherein R1R2 and R5 are each methyl, R3 is phenyl, R4 is hydrogen and X is chloride.
Claim 7
Dependent Claim 22 words
The composition of claim 1 wherein R1, R2 and R4 are methyl, R3 is phenyl, R5 is hydrogen and X is chloride.
Claim 8
Dependent Claim 26 words
The composition of claim 1 wherein R1 and R2 are each methyl, R3 and R5 are each phenyl, R4 is hydrogen and X is methyl sulfate.
Claim 9
Dependent Claim 25 words
The composition of claim 1 wherein R1 and R2 are each methyl, R3 is phenyl, R4 and R5 are each hydrogen and X is chloride.
Claim 10
Dependent Claim 25 words
The composition of claim 1 wherein R1 and R2 are each methyl, R3 is p-tolyl, R4 is methyl, R5 is hydrogen and X is iodide.
Claim 11
Dependent Claim 23 words
The composition of claim 1 wherein R1, R2 and R3 are each methyl, R4 is phenyl, R5 is hydrogen and X is chloride.
Claim 12
Dependent Claim 21 words
The composition of claim 1 wherein R1, R2, R4 and R5 are each methyl, R3 is phenyl and X is iodide.
Claim 13
Dependent Claim 22 words
The composition of claim 1 wherein R1 and R2 are each methyl, R4 is ethyl, R3 is phenyl and X is iodide.
Claim 14
Dependent Claim 48 words
A process for lowering of blood sugar levels in warm blooded animal subjects suffering from hyperglycemia which comprises orally administering to such subjects an effective blood sugar lowering amount of a compound selected from the group consisting of a 1,2-dilower alkyl arlypyrazolium quaternary salt of the followiNg formula:
Claim 15
Dependent Claim 12 words
The process of claim 15 wherein R1 and R2 are each methyl.
Claim 16
Dependent Claim 19 words
The process of claim 15 wherein R1 and R2 are each methyl and X is a pharmaceutically acceptable halide.
Claim 17
Dependent Claim 29 words
The process of claim 15 wherein R1 and R2 are each methyl, and R5 is a member selected from the group consisting of phenyl and phenyl substituted by methyl.
Claim 18
Dependent Claim 57 words
The process of claim 15 wherein R1 and R2 are each methyl, R3 is a member selected from the group consisting of phenyl and phenyl substituted by methyl, R4 is a member selected from the group consisting of hydrogen and lower alkyl and R5 is a member selected from the group consisting of hydrogen, methyl and phenyl.
Claim 19
Dependent Claim 63 words
The process of claim 15 wherein R1 and R2 are each methyl, R3 is a member selected from the group consisting of phenyl and phenyl substituted by methyl, R4 is a member selected from the group consisting of hydrogen, methyl and ethyl, R5 is a member selected from the group consisting of hydrogen, methyl and phenyl and X is a pharmaceutically acceptable halide.
Claim 20
Dependent Claim 23 words
The process of claim 15 wherein R1, R2 and R5 are each methyl, R3 is phenyl, R4 is hydrogen and X is chloride.
Claim 21
Dependent Claim 22 words
The process of claim 15 wherein R1, R2 and R4 are methyl, R3 is phenyl, R5 is hydrogen and X is chloride.
Claim 22
Dependent Claim 26 words
The process of claim 15 wherein R1 and R2 are each methyl, R3 and R5 are each phenyl, R4 is hydrogen and X is methyl sulfate.
Claim 23
Dependent Claim 24 words
The process of claim 15 wherein R1 and R2 are each methyl, R3 is phenyl, R4 and R5 are hydrogen and X is chloride.
Claim 24
Dependent Claim 23 words
The process of claim 15 wherein R1, R2 and R4 are each methyl, R3 is p-tolyl, R5 is hydrogen and X is iodide.
Claim 25
Dependent Claim 23 words
The process of claim 15 wherein R1, R2 and R3 are each methyl, R4 is phenyl, R5 is hydrogen and X is chloride.
Claim 26
Dependent Claim 21 words
The process of claim 15 wherein R1, R2, R4 and R5 are each methyl, R3 is phenyl and X is iodide.
Claim 27
Dependent Claim 22 words
The process of claim 15 wherein R1 and R2 are each methyl, R4 is ethyl, R3 is phenyl and X is iodide.

References Cited (Backward Citations)

US3350407A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1977-06-17 1977-12-17 1978-06-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1981-06-17 1981-12-17 1982-06-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1985-06-17 1985-12-17 1986-06-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag